loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of All Manufacturers & Suppliers for 22150 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ICATIBANT ACETATE (1)

filter

01 TAKEDA PHARMS USA (1)

filter

01 INJECTABLE;SUBCUTANEOUS (1)

filter

01 EQ 30MG BASE/3ML (EQ 10MG BASE/ML) (1)

filter

01 USA (1)

URL Supplier Web Content
INJECTABLE;SUBCUTANEOU...
EQ 30MG BASE/3ML (EQ 1...
FIRAZYR
USA
22150
2011-08-25
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 22150

Looking for CTD TGA MCC DOSSIER APPLICATION 22150 1

19

Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ICATIBANT ACETATE, with a corresponding application number 22150 and regulatory information .

proudly manufactured in the

approval since 2011-08-25

Takeda Pharmaceutical's FIRAZYR INJECTABLE;SUBCUTANEOUS, medication with EQ 30MG BASE/3ML (EQ 10MG BASE/ML) of ICATIBANT ACETATE.

Post Enquiry
POST ENQUIRY